Cargando…
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives
One in four breast cancer patients is at risk of developing bone metastases in her life time. The early prevention of bone metastases is a crucial challenge. It has been suggested that the use of zoledronic acid (ZOL) in the adjuvant setting may reduce the persistence of disseminated tumor cells and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449698/ https://www.ncbi.nlm.nih.gov/pubmed/26237389 http://dx.doi.org/10.3390/jcm3020521 |